Steven N. Hochwald0000-0002-4392-2852
Steven N. Hochwald is the Vice Chair, Chief of Gastrointestinal (GI) Surgery and Professor of oncology at the Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA. He was most recently the Edward M. Copeland Professor of surgical oncology at the University of Florida (UF) and Chief of the Division of Surgical Oncology and Physician Leader of the GI Oncology Center at UF’s Shands Cancer Center. After earning a B.S. degree in biology from John Hopkins University, Hochwald went on to receive an M.D. from New York University (NYU). He did his residency at the NYU Medical Center Department of Surgery, serving as Executive Chief Resident from 1996 to 1997, and completed clinical and research fellowships in surgical oncology at Memorial Sloan-Kettering Cancer Center. Hochwald's areas of expertise are colorectal, esophageal, liver, pancreatic, small intestine, and stomach cancers. His research interests are design, synthesis, and evaluation of novel selective inhibitors of FAK and IGF-1R function in cancer, targeted, image-guided release of combinatorial FAK inhibitors in pancreatic cancer, novel agents that target FAK and IGF-1R protein interactions, FAK and IGF-1R interactions in pancreatic cancer survival, nanoparticle-directed therapy for GI malignancy, technical advances in minimally invasive esophagectomy and minimally invasive gastrectomy, and outcomes for patients undergoing surgical therapy for upper gastrointestinal cancers.
Biography Updated on 30 April 2013